ADVERTISEMENT
Business Briefs: BrightView, Altruix, Summit BHC, SpectrumAi
BrightView Opens 12 Facilities in Massachusetts
Outpatient addiction treatment provider BrightView Health announced this week that it has opened 12 facilities in Massachusetts. The new locations expand on a BrightView network that includes more than 80 facilities in North Carolina, Virginia, Ohio, Kentucky, Delaware, Arizona, and Maryland.
The Massachusetts programs will take walk-in patients, offer same-day appointments, and accept all insurance.
BrightView’s programs include medication-assisted treatment (MAT), counseling, group therapy, peer support, and social services, as well as telehealth-based and virtual treatment options.
Behavioral Pharmacy Platform Rebrands as Altruix
WindRose Health Investors, a healthcare-focused private equity firm, announced on Wednesday that its behavioral focused pharmacy platform is consolidating its operations under the new name of Altruix. The name change will go into effect in May.
Based in Annapolis, Maryland, the platform provides distribution and medication adherence services primarily for patients who are being treated for severe and persistent mental illness, substance use disorders, and intellectual and developmental disabilities. Altruix serves more than 22,000 patients in 23 states through 7 closed-door pharmacies.
Summit BHC Appoints New Chief Strategy Officer
Summit BHC, a national provider of behavioral health and addiction treatment services, announced on Monday that it has appointed Chuck Steiner as its new chief strategy officer.
Steiner joins the Franklin, Tennessee-based organization with 15 years of experience in healthcare. Most recently, he served as senior vice president of mergers and acquisitions and development at Shields Healthcare Solutions. Shields was acquired by Walgreens Boots Alliance in 2022.
SpectrumAi Secures $20 Million in Series A Funding
SpectrumAi, a developer of solutions for autism care, announced on Thursday that it has closed up to $20 million in Series A funding. The round was led by CVS Health Ventures, with participation from Cobalt Ventures and follow-on investments from seed investors F-Prime, Frist Cressey, and Autism Impact Fund.
SpectrumAi said in a news release that the financing will accelerate adoption of its electronic health record (EHR), known as Twyll, and network analytics platform, known as Patterns—2 tools designed to improve data capture and objective measurement of applied behavior analysis therapy (ABA) for autism.
References
